Pain management beyond opioids: a β-arrestin2-biased allosteric GPCR modulator opens new avenues for drug development.
Saved in:
| Title: | Pain management beyond opioids: a β-arrestin2-biased allosteric GPCR modulator opens new avenues for drug development. |
|---|---|
| Authors: | Pottie E; Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium., Steinmüller SAM; School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen Foresterhill, Aberdeen, UK., Decker M; Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg (JMU), Würzburg, Germany. michael.decker@uni-wuerzburg.de. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2025 Aug 27; Vol. 10 (1), pp. 264. Date of Electronic Publication: 2025 Aug 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
